Dignitana Publishes Annual Report for 2017
Dignitana Årsredovisning - Dignitana AB (publ_) 2017 - wkr0006.pdf
Lund, Sweden – 3 April 2018 – Dignitana AB hereby publishes the annual report for 2017. The annual report is attached to this press release and can be downloaded from the website www.dignitana.se. You can also order a printed version via investorrelations@dignitana.com.Note: This report is published in Swedish.
Note: For a similar report in English, view the Dignitana 2017 Year End Report that was released 22 February 2018.
-----------------------------------
Dignitana AB publicerar årsredovisningen för 2017
Lund, Sweden – 3 April 2018 – Dignitana AB offentliggör härmed årsredovisningen avseende 2017. Årsredovisningen finns som bilaga till detta pressmeddelande samt går att ladda ner från hemsidan, www.dignitana.se. Det går även att beställa en utskriven version via investorrelations@dignitana.com.
Obs! Denna rapport är publicerad på svenska. För en liknande rapport på engelska, se Dignitana 2017 Year End Report som släpptes den 22 Februari 2018.
-----------------------------------
The above is information that Dignitana AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, by the above contact, for publication at 8:05 CEST 3 April 2018.
Investor Relations
Melissa Bourestom
Dignitana
00 1 773 387 8504
investorrelations@dignitana.com
Media Contact
Caren Browning
King + Company
00 1 212 561 7464
About Dignitana AB (publ)
Dignitana is a Swedish public company based in Lund and manufacturer of the medical cooling device DigniCap®. Dignitana AB is listed on Nasdaq First North Stockholm and has appointed Erik Penser Bank as Certified Adviser. Headquartered in Dallas Texas, Dignitana, Inc. is the U.S. subsidiary of Dignitana AB. DigniCap®is a patented scalp cooling system that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and acceptable patient comfort.
For more information visit www.dignitana.se and www.dignicap.com.
DigniCap long-term study demonstrates safety and efficacy of scalp cooling to reduce chemo hair loss
Dignitana expands customer service coverage in Europe with oneservice partnership
Dignitana expands partnership with Celeritas to improve scalp cooling technology available in Mexico
Dignitana announces proposal for Local Coverage Determination of scalp cooling therapy
Dignitana enters Hong Kong market with leading distributor Science International Corporation
Dignitana newsletter highlights growth, media coverage and exemplary customer satisfaction